Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179949 | SCV000232270 | uncertain significance | not provided | 2014-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000179949 | SCV002406895 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002515287 | SCV003655434 | likely benign | Inborn genetic diseases | 2022-07-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000179949 | SCV005382890 | uncertain significance | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |